Tag: #cost

Small Business Finance

The Rising Cost of Cyber Crime: How Small Businesses Are Fighting Back Against Malware and Digital Threats

Tuesday, October 27, 2026 | 00:00

In an era where digital operations are central to commerce, cyber security has transitioned from an IT background concern to an existential boardroom priority. Government findings paint a stark picture of the modern threat landscape: the average cyber attack on an individual UK business costs a staggering £195,000. Across the broader economy, these breaches drain […]

Small Business Finance

Mastering Overhead and Margins: Essential Cost-Control Strategies for Small Businesses

Sunday, October 25, 2026 | 12:00

Effective cost control and the careful reduction of overhead expenses remain fundamental pillars for maintaining healthy profit margins in the small business sector. As business owners navigate shifting economic landscapes, managing daily expenditures can often mean the difference between long-term sustainability and financial distress. To help enterprises better understand and optimize their outgoings, a collaborative […]

Retirement & Insurance

The Estimator Is a Tool, Not an Appraiser: Michael Gay Examines Commercial Replacement Cost Valuations

Wednesday, October 21, 2026 | 07:01

This is the second installment in a specialized series of guest contributions from industry veteran Michael Gay. Throughout his extensive career in property and casualty insurance, Gay has observed firsthand how technological advancements in underwriting tools can sometimes create a false sense of security for insurance professionals and their clients alike. Commercial replacement cost estimating […]

Venture Capital & Startups

Denver Startup Intero Biosystems Ships Lab-Grown Human Intestines to Tackle the High Cost of Drug Failure

Monday, October 12, 2026 | 14:44

For decades, the pharmaceutical industry has relied heavily on animal models to test the safety and efficacy of emerging therapeutics. Yet, fundamental biological differences between species mean that a drug performing successfully in a mouse or a larger animal frequently fails when translated to human clinical trials. Most pharmaceutical candidates still ultimately fail during development, […]